EA199800993A1 - Композиции, содержащие фосфатидные кислоты - Google Patents

Композиции, содержащие фосфатидные кислоты

Info

Publication number
EA199800993A1
EA199800993A1 EA199800993A EA199800993A EA199800993A1 EA 199800993 A1 EA199800993 A1 EA 199800993A1 EA 199800993 A EA199800993 A EA 199800993A EA 199800993 A EA199800993 A EA 199800993A EA 199800993 A1 EA199800993 A1 EA 199800993A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pct
compositions containing
phosphatidic acids
containing phosphatidic
sec
Prior art date
Application number
EA199800993A
Other languages
English (en)
Other versions
EA001159B1 (ru
Inventor
Авнер Шенфельд
Мейр Шиницкий
Original Assignee
Модус Байолоджикал Мембрейнс Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Модус Байолоджикал Мембрейнс Лтд. filed Critical Модус Байолоджикал Мембрейнс Лтд.
Publication of EA199800993A1 publication Critical patent/EA199800993A1/ru
Publication of EA001159B1 publication Critical patent/EA001159B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Липидный препарат, содержащий, по крайней мере, около 10% фосфатидной кислоты (РА), используется для лечения некоторых состояний или заболевания человека. Примерами подобных состояний или заболевания являются синдромы отмены или рак.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800993A 1996-05-08 1997-05-06 Композиции, содержащие фосфатидные кислоты EA001159B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11818096A IL118180A (en) 1996-05-08 1996-05-08 Pharmaceutical compositions comprising a phosphatidic acid (PA) enriched natural phospholipid preparation and the production of such preparation
PCT/IL1997/000147 WO1997041874A1 (en) 1996-05-08 1997-05-06 Phosphatidic acid-comprising compositions

Publications (2)

Publication Number Publication Date
EA199800993A1 true EA199800993A1 (ru) 1999-04-29
EA001159B1 EA001159B1 (ru) 2000-10-30

Family

ID=11068848

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800993A EA001159B1 (ru) 1996-05-08 1997-05-06 Композиции, содержащие фосфатидные кислоты

Country Status (14)

Country Link
US (2) US6051564A (ru)
EP (1) EP0904087B1 (ru)
JP (2) JP3798817B2 (ru)
KR (1) KR100404693B1 (ru)
CN (1) CN1205937C (ru)
AT (1) ATE224719T1 (ru)
AU (1) AU718255B2 (ru)
BR (1) BR9708925A (ru)
CA (1) CA2253545C (ru)
DE (1) DE69715841T2 (ru)
EA (1) EA001159B1 (ru)
HK (1) HK1020882A1 (ru)
IL (1) IL118180A (ru)
WO (1) WO1997041874A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121322A (en) * 1997-07-16 2002-07-25 Modus Biolog Membranes Ltd Modular pharmacological preparation of the immune system based on fats and its preparation
AU6595900A (en) * 1999-08-18 2001-03-13 Kyowa Hakko Kogyo Co. Ltd. Hair growth stimulants
IL134240A0 (en) * 2000-01-27 2001-04-30 Senyorina Ltd Inositol derivatives and their pharmaceutical use
AU2007205762B2 (en) * 2000-08-09 2011-07-14 Kabushiki Kaisha Yakult Honsha Process for the production of phospholipids
IL139224A (en) * 2000-10-23 2009-09-01 David Rutenberg Anti depressant, stress suppressor and mood improver
WO2005044176A2 (en) * 2003-11-10 2005-05-19 Lipogen Ltd. Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same
AU2005265998A1 (en) * 2004-07-27 2006-02-02 Modus Biological Membranes Ltd. Compositions and methods for smoking cessation
US7639887B2 (en) 2004-12-14 2009-12-29 Intel Corporation Error diffusion-based image processing
WO2007026358A2 (en) * 2005-08-31 2007-03-08 Modus Biological Membranes Ltd. Compositons comprising phosphatidic acid for treatment of eosinophilia and related disorders
US9248137B2 (en) * 2009-10-27 2016-02-02 Lipogen Ltd. Compositions and methods for alleviating symptoms associated with perimenopausal and/or menopausal disorder or discomfort
US10869843B2 (en) 2010-11-23 2020-12-22 Chemi Nutra Method for increasing muscle mass and strength
JP2015044872A (ja) * 2014-12-08 2015-03-12 ユニチカ株式会社 生体コラーゲン合成促進剤
WO2020213983A1 (ko) 2019-04-19 2020-10-22 한양대학교 산학협력단 포스파티딘산 함유 온도 감응성 조성물 및 이의 용도
KR20220050811A (ko) 2020-10-16 2022-04-25 한양대학교 산학협력단 포스파티딘산 함유 자궁내막증 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
JPH0724548B2 (ja) * 1988-07-15 1995-03-22 花王株式会社 食用油脂組成物
JP2981294B2 (ja) * 1991-02-22 1999-11-22 花王株式会社 ホスファチジン酸の製造方法
JPH06116149A (ja) * 1992-10-02 1994-04-26 Eisai Co Ltd 神経修復剤
AU1743495A (en) * 1994-02-04 1995-08-21 Cell Therapeutics, Inc. Composition for wound healing, neuron growth and vascularization

Also Published As

Publication number Publication date
CN1205937C (zh) 2005-06-15
CA2253545A1 (en) 1997-11-13
CA2253545C (en) 2005-07-05
JP2006143744A (ja) 2006-06-08
US6051564A (en) 2000-04-18
EP0904087A1 (en) 1999-03-31
HK1020882A1 (en) 2000-05-26
AU718255B2 (en) 2000-04-13
JP2000510116A (ja) 2000-08-08
AU2648897A (en) 1997-11-26
BR9708925A (pt) 2000-01-04
ATE224719T1 (de) 2002-10-15
IL118180A (en) 2000-12-06
EP0904087B1 (en) 2002-09-25
IL118180A0 (en) 1996-09-12
US6358937B1 (en) 2002-03-19
EA001159B1 (ru) 2000-10-30
CN1221343A (zh) 1999-06-30
JP3798817B2 (ja) 2006-07-19
KR20000010860A (ko) 2000-02-25
KR100404693B1 (ko) 2003-12-18
DE69715841T2 (de) 2003-06-18
WO1997041874A1 (en) 1997-11-13
DE69715841D1 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
SE9604793D0 (sv) New polymorphs
EA199800993A1 (ru) Композиции, содержащие фосфатидные кислоты
DE69718177D1 (de) Substituierte pyrimidinderivate und ihre pharmazeutische anwendung
NO2015027I2 (no) Mepolizumab
IE840302L (en) 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
IL114446A (en) Pharmaceutical preparation for pain management and process for its preparation
GR3034991T3 (en) Dihydrobenzofuranes
DE69616333D1 (de) Thip zur behandlung von schlafstörungen
HK1018701A1 (en) Benzopyran derivatives having leukotriene-antagonistic action.
ATE204861T1 (de) Verfahren zur herstellung von 2,2'-bipyrrolyl- pyrromethen-derivaten (prodigiosine)
PL322802A1 (en) Derivatives of 10,13,15-trioxatricyclo[9.2.1.1]-pentadecanone, method of obtaining them and therapeutic agents containing such compounds
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
FI881413A (fi) Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
DE3587499D1 (de) Primycinkomponenten und verfahren zur trennung des antibiotischen komplexes.
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
AU3868895A (en) Process for the preparation of furosemide
SE9404438D0 (sv) New process
FR2754824B1 (fr) Nouvelle composition contenant du chitosan
AU3473595A (en) Novel phosphane oxides, method of preparing them and drugs containing these compounds
IT1275436B (it) Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
DE69618340D1 (de) Verfahren zur herstellung von substituierten anthrachinonen und deren verwendung zur herstellung von rheinen
DE3880072D1 (de) N-phenyl-2,2,6,6-tetrahalogencyclohexanimin und verfahren zur herstellung von derivaten des 2,2,6,6-tetrahalogencyclohexanimins und von derivaten des 2,6-dihalogenanilins.
FR2766669B1 (fr) Emulsion de glyphosate, l'un de ses procedes de preparation et composition phyto-toxique en contenant
ATE184650T1 (de) Verfahren zur herstellung von spirolaxin und spirolaxinmethylether

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU